Literature DB >> 12952837

Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans.

Prashanthan Sanders1, Joseph B Morton, Neil C Davidson, Steven J Spence, Jitendra K Vohra, Paul B Sparks, Jonathan M Kalman.   

Abstract

BACKGROUND: Atrial fibrillation (AF) frequently complicates congestive heart failure (CHF). However, the electrophysiological substrate for AF in humans with CHF remains unknown. We evaluated the electrophysiological and electroanatomic characteristics of the atria in patients with CHF. METHODS AND
RESULTS: Twenty-one patients (aged 53.7+/-13.6 years) with symptomatic CHF (left ventricular ejection fraction 25.5+/-6.0%) and 21 age-matched controls were studied. The following were evaluated: effective refractory periods (ERPs) from the high and low lateral right atrium (LRA), high septal right atrium, and distal coronary sinus (CS); conduction time along the CS and LRA; corrected sinus node recovery times; P-wave duration; and conduction at the crista terminalis. In a subset, electroanatomic mapping was performed to determine atrial activation, regional conduction velocity, double potentials, fractionated electrograms, regional voltage, and areas of electrical silence. Patients with CHF demonstrated an increase in atrial ERP with no change in the heterogeneity of refractoriness, an increase of atrial conduction time along the LRA and the CS, prolongation of the P-wave duration and corrected sinus node recovery times, and greater number and duration of double potentials along the crista terminalis. Electroanatomic mapping demonstrated regional conduction slowing with a greater number of electrograms with fractionation or double potentials, associated with areas of low voltage and electrical silence (scar). Patients with CHF demonstrated an increased propensity for AF with single extrastimuli, and induced AF was more often sustained.
CONCLUSIONS: Atrial remodeling due to CHF is characterized by structural changes, abnormalities of conduction, sinus node dysfunction, and increased refractoriness. These abnormalities may be responsible in part for the increased propensity for AF in CHF.

Entities:  

Mesh:

Year:  2003        PMID: 12952837     DOI: 10.1161/01.CIR.0000090688.49283.67

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  149 in total

1.  Valsartan in acute myocardial infarction trial.

Authors:  Ileana L Piña
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

Review 2.  Renal denervation: effects on atrial electrophysiology and arrhythmias.

Authors:  Dominik Linz; Arne van Hunnik; Christian Ukena; Sebastian Ewen; Felix Mahfoud; Stephan H Schirmer; Matthias Lenski; Hans-Ruprecht Neuberger; Ulrich Schotten; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2014-03-29       Impact factor: 5.460

3.  Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm.

Authors:  P Kiès; C Leclercq; G B Bleeker; C Crocq; S G Molhoek; C Poulain; L van Erven; M Bootsma; K Zeppenfeld; E E van der Wall; J-C Daubert; M J Schalij; J J Bax
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

Review 4.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 5.  Report on the Ion Channel Symposium : Organized by the German Cardiac Society Working Group on Cellular Electrophysiology (AG 18).

Authors:  Niels Voigt; Fleur Mason; Dierk Thomas
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-01-08

6.  The prognostic impact of successful cardioversion of atrial fibrillation in patients with organic heart disease.

Authors:  T Kleemann; T Becker; K Dönges; M Vater; B Gut; S Schneider; J Senges; K Seidl
Journal:  Clin Res Cardiol       Date:  2006-11-24       Impact factor: 5.460

Review 7.  Atrial cardiopathy: a mechanism of cryptogenic stroke.

Authors:  Shadi Yaghi; Hooman Kamel; Mitchell S V Elkind
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-07-27

Review 8.  Atrial fibrillation and conduction system disease: the roles of catheter ablation and permanent pacing.

Authors:  Anand Thiyagarajah; Dennis H Lau; Prashanthan Sanders
Journal:  J Interv Card Electrophysiol       Date:  2018-08-03       Impact factor: 1.900

9.  P-wave indices and atrial fibrillation: cross-cohort assessments from the Framingham Heart Study (FHS) and Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Jared W Magnani; Lei Zhu; Faye Lopez; Michael J Pencina; Sunil K Agarwal; Elsayed Z Soliman; Emelia J Benjamin; Alvaro Alonso
Journal:  Am Heart J       Date:  2014-10-22       Impact factor: 4.749

10.  Electrocardiographic PR interval and adverse outcomes in older adults: the Health, Aging, and Body Composition study.

Authors:  Jared W Magnani; Na Wang; Kerrie P Nelson; Stephanie Connelly; Rajat Deo; Nicolas Rodondi; Erik B Schelbert; Melissa E Garcia; Caroline L Phillips; Michael G Shlipak; Tamara B Harris; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.